Novo supported the first close of 2150's debut fund, which was anchored by NREP, the property developer that also incubated the venture firm.
2150, a venture capital firm incubated by Denmark-headquartered real estate developer NREP, reached the €130m ($158m) first close of a flagship fund anchored by NREP, yesterday. Pharmaceutical company Novo, the Denmark state-backed Green Future Fund and investment firm Chr Augustinus Fabrikker have also committed to the fund together with unnamed family offices and investors from…
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.